Sana Biotechnology Inc

SANA

Company Profile

  • Business description

    Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

  • Contact

    188 East Blaine Street
    Suite 400
    SeattleWA98102
    USA

    T: +1 206 701-7914

    E: [email protected]

    https://www.sana.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    194

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,660.3022.500.26%
CAC 407,751.8927.83-0.36%
DAX 4023,997.4864.250.27%
Dow JONES (US)42,051.71164.02-0.39%
FTSE 1008,772.3855.930.64%
HKSE23,289.77283.61-1.20%
NASDAQ18,926.36249.51-1.30%
Nikkei 22537,965.10467.88-1.22%
NZX 50 Index12,418.89137.581.12%
S&P 5005,865.5546.62-0.79%
S&P/ASX 2008,434.7024.900.30%
SSE Composite Index3,347.4915.96-0.47%

Market Movers